Related Experiment Video
Updated: Jul 4, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Synthesis and Translational Assessment of Trinucleotide 5'-Cap Analogs for Messenger Ribonucleic Acid-Based
Jeeyeon Kim1,2, Kyeongwon Moon1, Jihun Kim1
1School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Researchers developed novel synthetic trinucleotide 5'-capping agents for messenger RNA (mRNA). A modified compound (43) showed high capping efficiency, enhanced translation, and superior stability against decapping enzymes, indicating its potential for mRNA therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Synthetic Chemistry
Background:
- Messenger RNA (mRNA) capping is a crucial post-transcriptional modification regulating gene expression.
- Synthetic mRNA cap analogs are being explored to enhance mRNA stability and translation efficiency for therapeutic applications.
Purpose of the Study:
- To synthesize and evaluate novel trinucleotide 5'-capping agents with 2'- and 3'-ribose modifications.
- To assess the capping efficiency, translational ability, and enzymatic stability of the synthesized compounds.
Main Methods:
- Synthesis of trinucleotide 5'-capping agents with specific ribose modifications.
- Evaluation of capping efficiency using biochemical assays.
- Assessment of translational activity via dual luciferase reporter assays.
- Testing resistance against decapping enzymes (DcpS and hDcp2).
- In vivo studies using lipid nanoparticles formulated with modified mRNA.
Main Results:
- The 3'-O-mesylated m7GpppAmG (43) achieved a high capping efficiency of 97.1%, comparable to commercial standards.
- Compound 43 demonstrated 1.8-fold higher translational ability than the commercial control in reporter assays.
- Compound 43 exhibited significant resistance to decapping enzymes, indicating enhanced biological stability.
- In vivo studies confirmed the translational competence of compound 43 when formulated into lipid nanoparticles with mRNA.
Conclusions:
- The novel trinucleotide 5'-capping agent (43) offers high efficiency, potent translation, and improved stability.
- This modified cap analog holds promise for advancing mRNA-based technologies and therapeutics.
Related Concept Videos
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl guanosine). This 5’ cap helps the...
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Leaky Scanning
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps the cell...
Nucleic Acid Structure
DNA Structure
DNA has a double-helix structure. The...

